Indeed, this co-stimulatory signal has taken relevance in different chronic inflammatory pathologies, bacterial infections, and cancer because the continuous activity of the CD28/CD86 axis may prevent T cell dysfunction and promote correct antigen clearance at the inflammatory site (65–67). Here, CD28 is linked to cancer.